Boothbay Fund Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.39M Buy
2023
Q3
Sell
2023
Q2
$31.5K Hold
2023
Q1
$28.9K Hold
2022
Q4
$44.6K Buy
2022
Q3
Hold
2022
Q2
Hold
2021
Q3
Sell
2021
Q2
$1.1M Buy
2021
Q1
$1.17M Buy